| Literature DB >> 34911197 |
Melissa Hwang1, Youkyung S Roh1, Jessica Talero1, Bruce M Cohen2, Justin T Baker3, Roscoe O Brady4, Dost Öngür3, Ann K Shinn5.
Abstract
BACKGROUND: Auditory hallucinations (AH) are typically associated with schizophrenia (SZ), but they are also prevalent in bipolar disorder (BD). Despite the large body of research on the neural correlates of AH in SZ, the pathophysiology underlying AH remains unclear. Few studies have examined the neural substrates associated with propensity for AH in BD. Investigating AH across the psychosis spectrum has the potential to inform about the neural signature associated with the trait of AH, irrespective of psychiatric diagnosis.Entities:
Keywords: Auditory hallucinations; Bipolar disorder; Cerebellum; Functional connectivity; Resting state functional magnetic resonance imaging; Schizophrenia
Mesh:
Year: 2021 PMID: 34911197 PMCID: PMC8636859 DOI: 10.1016/j.nicl.2021.102893
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.891
Participant Characteristics.
| 90 | ||||
| χ2 = 30.242 | ||||
| Schizophrenia (SZ), No. (%) | 68 (76%) | 16 (29%) | – | – |
| Bipolar Disorder (BD), No. (%) | 22 (24%) | 39 (71%) | – | – |
| 29 (18–57) | 26 (18–62) | |||
| 31 (38%) | 16 (29%) | χ2 = 0.447 | ||
| 11 (12%) | 5 (11%) | χ2 = 0.341 | ||
| 48 (53%) | 11 (20%) | χ2 = 15.717 | ||
| Visual Hallucinations, No. (%) | 37 (41%) | 5 (9%) | χ2 = 17.011 | |
| Tactile Hallucinations, No. (%) | 29 (32%) | 7 (13%) | χ2 = 6.952 | |
| Olfactory & Gustatory Hallucinations | 10 (11%) | 2 (4%) | ||
| 3.5 (1–7) | 1 (1–6) | z = 20.421 | ||
| 58 (32–102) | 54 (29–84) | |||
| Positive | 14 (6–29) | 14 (6–32) | ||
| Negative, median (range) | 12 (7–40) | 9 (7–28) | ||
| General Psychopathology, median (range) | 29.5 (16–56) | 28 (16–46) | ||
| 6 (0–30) | 14 (0–37) | |||
| 15.5 (0–44) | 12 (0–40) | |||
| 300 (0–1959) | 200 (0–1175) | |||
| 3 (0–10) | 4 (0–11) | |||
| Alcohol, No. (%) | 5 (6%) | 2 (4%) | χ2 = 0.274 | |
| Cannabis, No. (%) | 13 (14%) | 9 (16%) | χ2 = 0.098 | |
| Stimulant and/or Cocaine | 2 (2%) | 1 (2%) | ||
| 3.5 (0–19) | 2 (0–15) |
Abbreviations: AH = Lifetime auditory hallucinations group; NAH = No lifetime auditory hallucinations group; SCID = Structured Clinical Interview for the DSM-IV-TR; PANSS = Positive and Negative Syndrome Scale; YMRS = Young Mania Rating Scale; MADRS = Montgomery-Asberg Depression Rating Scale; ART = ARtifact Detection Tool in Conn functional connectivity toolbox.
Variables with p-values in bold are included as covariates, along with ARtifact detection Tool (ART) outlier time points, in AH vs. NAH functional connectivity analyses.
Fisher’s exact test due to cell sizes < 5.
PANSS P3 Hallucination Item assessed current symptom severity, i.e., severity of hallucinations in the past month; therefore, patients with lifetime but no current AH could have a P3 score of 1 (absent) or 2 (minimal). P3 asks about hallucinations in any modality, and is not specific to AH; therefore, patients in the NAH group could have P3 scores > 2.
Symptom scale total calculated by excluding hallucination-related item.
Fig. 1ROI-to-ROI functional connectivity of patients with (AH) and without lifetime auditory hallucinations (NAH) across the psychosis spectrum. Compared to NAH patients, AH patients showed multiple regions (cerebral cortical and subcortical) that were functional hyperconnected to cerebellar regions, and hypoconnectivity between temporal lobe areas. Results were adjusted for motion, diagnosis, lifetime hallucinations in other modalities, negative symptom severity, mania severity, depression severity, and antipsychotic exposure as measured by chlorpromazine equivalents. The significance threshold was set at p < 0.05, two-sided, false discovery rate (FDR)-corrected for multiple comparisons.
Fig. 2Cerebello-cerebral cortical functional connectivity associated with lifetime AH across the psychosis spectrum. Compared to NAH patients, AH patients showed higher functional connectivity between cerebellum and regions in frontal, temporal, and parietal areas. The bar graphs show the Fisher-transformed Pearson’s correlation between example ROI-pairs, with healthy control data presented in dashed lines as a point of reference. The data show patients with AH to have increased connectivity relative to both NAH and also healthy controls.
Fig. 3Cerebello-subcortical functional connectivity associated with lifetime AH across the psychosis spectrum. Compared to NAH patients, AH patients showed higher functional connectivity between cerebellum and left nucleus accumbens and left pallidum. The bar graphs show the Fisher-transformed Pearson’s correlation between the two significant ROI-to-ROI findings, with healthy control data presented in dashed lines as a point of reference.
Fig. 4Functional connectivity between temporal lobe regions in association with lifetime AH across the psychosis spectrum. Compared to NAH patients, AH patients showed lower functional connectivity between temporal lobe areas within the right hemisphere as well as between hemispheres. The bar graphs show the Fisher-transformed Pearson’s correlation between example ROI-pairs, with healthy control data presented in dashed lines as a point of reference.
Fig. 5Functional connectivity of AH vs. NAH within each diagnostic category. (A) Schizophrenia AH vs. schizophrenia NAH. (B) Bipolar psychosis AH vs. bipolar psychosis NAH. (See supplementary materials for Fisher-transformed correlation coefficients.)